Presented at the American Society of Clinical Oncology 2020 (#ASCO20) Virtual Scientific Program, May 29 to May 31, 2020.
Ravi Salgia, Leigh Boehmer, Catherine Celestin, Judy Yu, David R. Spigel; The University of Chicago, Chicago, IL; Association of Community Cancer Centers, Rockville, MD; AstraZeneca, Gaithersburg, MD; Sarah Cannon Research Institute, Nashville, TN.
Refinement of the multidisciplinary team (MDT) approach continues to offer significant potential for improving the quality of non-small cell lung cancer (NSCLC) care and adherence to guideline-recommended protocols. This opportunity arises, in part, from insufficient characterization of MDT practice patterns and barriers to optimal care provision within U.S. cancer programs. The Association of Community Cancer Centers (ACCC), therefore, conducted a national survey to improve understanding on how patients with stage III/IV NSCLC were diagnosed and managed across different practice settings, with the aim of informing the design and execution of process-improvement plans to address identified barriers.
ASCO Abstract: What Defines Quality Lung Cancer Care?
This project is made possible by support from AstraZeneca.